Brief: Eckert & Ziegler: Australian Endocrine & Hypertension Center Joins Clinical Trial Of PentixaPharm
May 8 (Reuters) - Eckert & Ziegler Strahlen und
Medizintechnik AG EUZG.DE :
* EQS-NEWS: ECKERT & ZIEGLER: RECOGNIZED AUSTRALIAN
ENDOCRINE &
HYPERTENSION CENTER JOINS INTERNATIONAL GROUPS WITH A CLINICAL
TRIAL OF PENTIXAPHARM’S PRIMARY ALDOSTERONISM LEAD CANDIDATE
Source text for Eikon: ID:nEQ1WmcNMa
Further company coverage: EUZG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Eckert & Ziegler SE
See all newsBrief: Eckert & Ziegler Brazil And Terthera Sign Supply Agreement For Terbium-161
Germany's Eckert & Ziegler H1 net income rises, confirms FY view
Brief: Eckert & Ziegler - FY Outlook Confirmed
Brief: Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler
Germany's Eckert & Ziegler Q1 sales rise on medical segment growth